Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

I. Introduction The anatomic and clinical complexity of patients with coronary artery disease
(CAD) is increasing in the United States. 1–3 While the terms “complex CAD” or “high-risk …

Objective Systematic investigation of restenosis after percutaneous coronary intervention
(PCI) with bare metal stents (BMS) or first or second generation drug eluting stents (DES) in …

Background Treatment of coronary in-stent restenosis is hampered by a high incidence of
recurrent in-stent restenosis. We assessed the efficacy and safety of a paclitaxel-coated …

Background Recent reports have indicated that there may be an increased risk of late stent
thrombosis with the use of drug-eluting stents, as compared with bare-metal stents. Methods …

Objectives: This study was performed to evaluate the feasibility of the physiologic
assessment of jailed side branches using fractional flow reserve (FFR) and to compare the …

Aims In many countries, drug-eluting stent implantation is the dominant interventional
strategy. We evaluated the clinical, angiographic, procedural, and intravascular ultrasound …

Background—The efficacy of drug-eluting stents in reducing restenosis risk has not been
uniform across patient subsets. Identifying predictive factors of restenosis may help improve …

Objectives: This trial examined the relative clinical efficacy, angiographic outcomes, and
safety of zotarolimus-eluting coronary stents (ZES) with a phosphorylcholine polymer versus …

Objectives: The aim of the study was to investigate 4-year outcomes and predictors of repeat
revascularization in patients treated with the Resolute zotarolimus-eluting stent (R …